Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Cash Flows From Operating Activities:
Net loss	$ (2,790,505)	$ (908,289)	$ (7,314,519)	$ (4,159,000)
Adjustments to reconcile net loss to cash used in operating activities
Change in fair value of warrant liability	(1,969,922)	(2,459,543)	(2,245,891)	(6,272,543)
Change in fair value of derivative liability	53,000		53,000
Stock-based compensation			1,446,162	4,342,498
Inducement expense				298,714
Amortization of right-of-use asset			68,910
Amortization of intangible assets	42,187	174,019	84,375	310,659
Depreciation expense	43,315		70,392
Change in operating assets and liabilities:
Prepaid expenses and other current assets			(1,031,979)	(190,757)
Accounts payable and accrued liabilities			(187,902)	486,274
Right-of-use operating lease liability			(76,686)
Net cash used in operating activities			(9,134,138)	(5,184,155)
Cash Flows From Investing Activities:
Purchases of property and equipment			(559,398)
Purchase of license agreement				(675,000)
Net cash used in investing activities			(559,398)	(675,000)
Cash Flows From Financing Activities:
Proceeds from sale of common stock and warrants, net of offering costs			9,397,884	21,614,488
Proceeds from the sale of redeemable non-controlling interest, net of offering costs (see Note 6)			958,038
Proceeds from warrant exercises				3,285,173
Net cash provided by financing activities			10,355,922	24,899,661
Effect of foreign exchange rate on cash			(9,434)	(1,049)
Net increase in cash			652,952	19,039,457
Cash at beginning of period			17,355,999	1,578,460
Cash at end of period	18,008,951	$ 20,617,917	18,008,951	20,617,917
Supplemental disclosure of cash flow information:
Cash paid for interest			4,806
Supplemental disclosure of non-cash investing and financing activities:
Warrants issued in conjunction with common stock issuance			3,595,420
Issuance of embedded derivative			402,000
Issuance of redeemable non-controlling Series C preferred stock			527
Preferred dividends attributable to redeemable non-controlling interest	(7,808)		7,808
Accretion of embedded derivative to redemption value	$ (73,994)		$ 73,994